Gastro Health, a national leading medical group specializing in digestive and liver health, has signed a definitive agreement to partner with Digestive Disorders Associates based in Annapolis, Maryland. The deal is scheduled to close on July 1. Digestive Disorders Associates is joining with six physicians and three advanced practice providers (APPs). The practice has three office locations in Annapolis, Chester, and Gambrills. The physicians perform procedures at Maryland Diagnostic and Therapeutic Endo Center, which is accredited by the Accreditation Association for Ambulatory Health Care.
Author: Praveen Suthrum
Bethesda, MD (June 14, 2022) — The American Gastroenterological Association today released a series of evidence-based position statements that amount to a call to action for a national colorectal cancer screening approach, which would enable everyone to participate in colorectal cancer (CRC) screening programs without barriers. CRC experts developed eight statements, which highlight the continuum of CRC screening, identify barriers and provide a platform for physician groups, patient advocates, industry, employers, payers and the government to work together eliminate screening barriers.
Oregon and Kentucky recently enacted policies to eliminate financial disincentives that may have deterred people from undergoing a follow-up colonoscopy after a positive result on a noninvasive screening test for colorectal cancer (CRC).
In a new study published in Nature Microbiology, researchers demonstrated the power of integrating the microbiome and host gene expression data to provide insights into their combined role in gastrointestinal diseases. The microbiome consists of all microbes in the gut including bacteria, fungi, and viruses. This study focused on bacteria.
1. Clinical remission at 52 weeks was similar between ustekinumab and adalimumab. 2. Patient-reported outcomes of stool frequency and abdominal pain scores were lower in the ustekinumab group compared to adalimumab (p=0.019). Evidence Rating Level: 1 (Excellent)
GE Healthcare is rolling out a set of wireless, portable sensors designed to be worn by patients during their hospital stay, making it easier for clinicians to keep track of their vital signs without routine check-ins. The goal is to help keep a closer eye on inpatients and people recovering from surgery—while allowing them to stretch their legs and interact with visitors, without being confined to a hospital bed—and also alert healthcare providers to any early signs of deterioration that may require a move to intensive care.
A randomized clinical trial indicated that add-on baclofen may be of benefit to patients on adequate doses of proton pump inhibitors (PPI) with refractory gastroesophageal reflux disease (GERD). However, the benefit was limited to a subset of patients with positive symptom association probability (SAP), which was calculated using 24-hour combined multichannel intraluminal impedance and pH monitoring (24h pH-MII).
Oshi Health, the virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics, today announced that John Allen, MD, MBA, AGAF has joined its medical advisory board. An internationally renowned gastroenterologist and leader in the field who built one of the largest private practices in the United States, Dr. Allen has recently retired as the Chief Clinical Officer at the University of Michigan Medical Group and has been a past President & Chairman of the American Gastroenterological Association (AGA). He will apply his deep experience and expertise to help Oshi Health continue to expand its innovative, virtual-first care delivery…
At a fork in the road, Aditya Khosla, Ph.D., is taking the path less traveled: one that will take him away from PathAI, the company he helped start half a decade ago. Khosla, who has also served as chief technology officer of the startup since its 2016 founding, will take on the same role at Iterative Scopes, which was founded one year after PathAI and is located in Cambridge, Massachusetts, just across the Charles River from PathAI’s Boston headquarters.
Gastroenterology is the sixth wealthiest speciality, according to Medscape’s Physician Wealth & Debt Report 2022. The report, released June 10, surveyed 13,064 physicians from Oct. 5, 2021, to Jan. 19. Read more about the methodology here.